Tadalista, which contains Tadalafil, is primarily used to treat erectile dysfunction (ED), but it is sometimes prescribed for pulmonary arterial hypertension (PAH) as well. PAH is a condition where the blood pressure in the arteries of the lungs becomes abnormally high, which can lead to shortness of breath, fatigue, and heart complications.
Why Tadalista Is Prescribed for PAH:
Vasodilation: Tadalafil, the active ingredient in Tadalista works by inhibiting the enzyme phosphodiesterase type 5 (PDE5). This action helps relax and widen the blood vessels, improving blood flow. In PAH, the blood vessels in the lungs become constricted, increasing the pressure. Tadalafil helps relax these blood vessels, reducing the pressure in the lungs.
Improved Exercise Capacity: By reducing pulmonary artery pressure, Tadalista can help improve the exercise capacity and overall quality of life for individuals with PAH. It helps increase blood flow to the lungs, allowing the heart to pump more efficiently.
FDA Approval: Tadalafil is approved by the FDA for the treatment of PAH under the brand name Adcirca, which is essentially the same medication but marketed specifically for PAH.
Tadalista is prescribed for PAH because of its ability to relax blood vessels in the lungs, reduce pulmonary artery pressure, and improve symptoms like shortness of breath and fatigue. Always follow a healthcare provider’s instructions when using this medication for PAH.
Our Mission... “To assist disaster survivors by providing a source for them to come together in time of need, to aid in the listing of events, information and other forms of assistance, and continuing support through the recovery process.”
Share this page with your family and friends.